OTCMKTS:RDSMY - Koninklijke DSM Stock Price, News & Analysis

-0.35 (-1.12 %)
(As of 09/15/2019 10:16 AM ET)
Today's Range
Now: $30.8650
50-Day Range
MA: $31.02
52-Week Range
Now: $30.8650
Volume53,491 shs
Average Volume46,865 shs
Market Capitalization$22.40 billion
P/E Ratio17.94
Dividend Yield1.10%
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and materials businesses in the Netherlands, North America, the United Kingdom, France, Germany, Switzerland, the Asia-Pacific, and internationally.. The company operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers nutrients, such as vitamins, carotenoids, nutritional lipids, and other ingredients to feed, food, pharmaceutical, and personal care industries; and food enzymes, cultures, yeast extracts, savory flavors, hydrocolloids, and other specialty ingredients for dairy, baking, beverage, and savory applications. Read More…

Industry, Sector and Symbol

Industry Chemicals & allied products
SectorBasic Materials
Previous SymbolNASDAQ:RDSMY



Sales & Book Value

Annual Sales$10.94 billion
Cash Flow$2.4831 per share
Book Value$12.72 per share


Net Income$1.27 billion


Market Cap$22.40 billion
Next Earnings Date9/18/2019 (Estimated)
OptionableNot Optionable

Receive RDSMY News and Ratings via Email

Sign-up to receive the latest news and ratings for RDSMY and its competitors with MarketBeat's FREE daily newsletter.

Koninklijke DSM (OTCMKTS:RDSMY) Frequently Asked Questions

What is Koninklijke DSM's stock symbol?

Koninklijke DSM trades on the OTCMKTS under the ticker symbol "RDSMY."

When is Koninklijke DSM's next earnings date?

Koninklijke DSM is scheduled to release their next quarterly earnings announcement on Wednesday, September 18th 2019. View Earnings Estimates for Koninklijke DSM.

What is the consensus analysts' recommendation for Koninklijke DSM?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Koninklijke DSM in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Koninklijke DSM.

Has Koninklijke DSM been receiving favorable news coverage?

Press coverage about RDSMY stock has trended somewhat positive this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Koninklijke DSM earned a media sentiment score of 0.9 on InfoTrie's scale. They also assigned news articles about the basic materials company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Koninklijke DSM.

Who are some of Koninklijke DSM's key competitors?

What other stocks do shareholders of Koninklijke DSM own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Koninklijke DSM investors own include Hawkins (HWKN), CA (CA), Endologix (ELGX), Resources Connection (RECN), BlackRock (BLK), Charles Schwab (SCHW), Athabasca Oil (ATH), Apollo Commercial Real Est. Finance (ARI), AutoZone (AZO) and Prudential (PRU).

Who are Koninklijke DSM's key executives?

Koninklijke DSM's management team includes the folowing people:
  • Mr. Feike Sijbesma, Chairman of the Managing Board & CEO (Age 60)
  • Ms. Geraldine Matchett, CFO & Member of the Managing Board (Age 47)
  • Mr. Dimitri de Vreeze, Member of the Managing Board (Age 52)
  • Mr. Jos Op Heij, Sr. VP of Corp. Control & Accounting and Group Controller
  • Marcus Remmers, Chief Technology Officer

How do I buy shares of Koninklijke DSM?

Shares of RDSMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Koninklijke DSM's stock price today?

One share of RDSMY stock can currently be purchased for approximately $30.8650.

How big of a company is Koninklijke DSM?

Koninklijke DSM has a market capitalization of $22.40 billion and generates $10.94 billion in revenue each year. The basic materials company earns $1.27 billion in net income (profit) each year or $1.73 on an earnings per share basis. Koninklijke DSM employs 20,977 workers across the globe.View Additional Information About Koninklijke DSM.

What is Koninklijke DSM's official website?

The official website for Koninklijke DSM is http://www.dsm.com/.

How can I contact Koninklijke DSM?

Koninklijke DSM's mailing address is Het Overloon 1, Heerlrn P7, 6411 TE. The basic materials company can be reached via phone at 31-45-578-2864.

MarketBeat Community Rating for Koninklijke DSM (OTCMKTS RDSMY)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  145 (Vote Outperform)
Underperform Votes:  158 (Vote Underperform)
Total Votes:  303
MarketBeat's community ratings are surveys of what our community members think about Koninklijke DSM and other stocks. Vote "Outperform" if you believe RDSMY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RDSMY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel